This innovative 3D bioprinting technology will be offered to third parties by a wholly owned private MeaTech subsidiary as an additional revenue stream and to accelerate commercialization
This innovative 3D bioprinting technology will be offered to third parties by a wholly owned private MeaTech subsidiary as an additional revenue stream and to accelerate commercialization